The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma

European Journal of Clinical Investigation

Volumn 28, Issue 7, 1998, Pages 584-591

  Freeman, D J ^a,b   Caslake, M J ^a   Griffin, B A ^a   Hinnie, J ^a   Tan, C E ^a   Watson, T D G ^a   Packard, C J ^a   Shepherd, J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Acyl transferase; Cholesteryl ester transfer protein; High density lipoprotein; Lecithin:cholesterol; Post heparin hepatic lipase; Post heparin lipoprotein lipase; Smoking

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN METABOLISM; LIVER; MALE; PLASMA; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCOPROTEINS; HEPARIN; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; REFERENCE VALUES; SMOKING; TRIGLYCERIDES;

EID: 0031857139     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00328.x     Document Type: Article

References (40)

1. Freeman DJ, Griffin BA, Murray E et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993; 23: 630-40.
2. Moriguchi EH, Fusegawa Y, Tamachi H, Goto Y. Effects of smoking on HDL subfractions in myocardial infarction patients: effects on lecithin-cholesterol acyl transferase and hepatic lipase. Clin Chim Acta 1990; 195: 139-44.
3. Eliasson B, Mero N, Taskinen M-R, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129: 79-88.
4. Dullart RPF, Hoogenberg K, Dikkeschu BD, Van Tol A. High plasma lipid transfer protein activities and unfavourable lipoprotein changes in cigarette smoking men. Arterioscler Thromb 1994; 14: 1581-5.
5. Haffner SM, Applebaum-Bowden D, Wahl PW et al. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II and D, and lecithin cholesterol acyl transferase. Arteriosclerosis 1985; 5: 169-77.
6. McCall MR, van den Berg JJM, Kuypers FA et al. Modification of LCAT activity and HDL structure, new links between cigarette smoke and coronary heart disease. Arterioscler Thromb 1994; 14: 248-53.
7. Elkeles RS, Khan SR, Chowdhury V, Swallow MB. Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci 1983; 65: 669-72.
8. Axelsen M, Eliasson B, Joheim E, Lenner RA, Taskinen MR, Smith U. Lipid intolerance in smokers. J Intern Med 1995; 237: 449-55.
9. Chajek-Shaul T, Friedman G, Dabach Y et al. The effect of acute and chronic administration of nicotine on lipoprotein lipase activity. Inter Angio 1987; 6: 29-36.
10. Brunzell JD, Goldberg AP, Schwartz RS. Cigarette smoking and adipose tissue lipoprotein lipase. Int J Obes 1980; 4: 101-3.
11. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. New Engl J Med 1989; 320: 1060-8.
12. Packard CJ, Shepherd J. Lipoprotein metabolism in lipase deficient states: studies in primary and secondary hyperlipidaemia. Biochem Soc Transactions 1993; 21: 503-6.
13. Newnham HH, Barter PJ. Synergistic effects of lipid transfers and hepatic lipase in the formation of very small high-density lipoproteins during incubation of human plasma. Biochim Biophys Acta 1990; 1044: 57-64.
14. Clay MA, Newnham HH, Forte TM, Barter PJ. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992; 1124: 52-8.
15. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by ApoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: effects of gender, hepatic and lipoprotein upases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 1994; 14: 707-20.
16. Lipid Research Clinics Program Lipid and lipoprotein analysis. Manual of Laboratory Operations, Vol. 1. Department of Health, Education and Welfare Publication No 75-628. Bethesda, MD: National Institutes of Health 1974.
17. Shepherd J, Caine EA, Bedford DK, Packard CJ. Ultracentrifugal subfractionation of high-density lipoprotein. Analyst 1984; 109: 347-51.
18. Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 1990; 79: 575-81.
19. Gillet MPT, Owen JS. Cholesterol esterifying enzymes -lecithin: cholesterol acyl transferase (LCAT) and acylcoenzyme A:cholesterol acyl transferase (ACAT). In: Converse CA, Skinner ER, eds. Lipoprotein Analysis: a Practical Approach. Oxford: IRL Press at Oxford University Press 1992: 187-96.
20. Watson TDG, Burns L, Packard CJ, Shepherd J. Selective determination of lipoprotein lipase and hepatic triglyceride lipase in heparinized plasma from horses. Am J Vet Res 1992; 53: 771-5.
21. Warwick GL, Packard CJ, Stewart JP, Watson TDG, Burns L, Boulton-Jones JM, Shepherd J. Post-prandial lipoprotein metabolism in nephrotic syndrome. Eur J Clin Invest 1992; 22: 813-20.
22. Belfrage P, Vaughan M. Simple liquid-liquid partition system for isolation of labelled oleic acid from glycerides. J Lipid Res 1969; 10: 341-4.
23. Baginsky ML, Brown WV. A new method for the measurement of lipoprotein lipase in post-heparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase. J Lipid Res 1979; 20: 548-56.
24. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations, analysis of published data. Br Med J 1989; 298: 784-8.
25. Freeman DJ, Packard CJ. Smoking and plasma lipoprotein metabolism. Clin Sci 1995; 89: 333-42.
26. Miesenbrock G, Holzl B, Foger B et al. Heterozygous deficiency due to missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993; 91: 448-55.
27. Swank AM, Fell RD. Effects of acute smoking and exercise on high-density lipoprotein-cholesterol and subfractions in black female smokers. Metabolism 1990; 39: 343-8.
28. Marcel YL, McPherson R, Hogue M et al. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidaemic subjects. J Clin Invest 1990; 85: 10-7.
29. Lamarche B, Despres JP, Moorjani S et al. Evidence for a role of insulin in the regulation of abdominal adipose tissue lipoprotein lipase response to exercise training in obese women. Int J Obes Relat Metab Disord 1993; 17: 255-61.
30. Lithell H, Boberg J, Hellsing K, Lundqvist G, Vessby B. Increase of the lipoprotein-lipase activity in human skeletal muscle during clofibrate administration. Eur J Clin Invest 1978; 8: 67-74.
31. Zechner R. The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr Opin Lipidol 1997; 8 (2): 77-88.
32. Freeman DJ, Griffin BA, Holmes AP et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the Taq IB RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994; 14: 336-44.
33. Tato F, Vega GL, Grundy SM. Determinants of plasma HDL-cholesterol in hypertriglyceridaemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vase Biol 1997; 17: 56-63.
34. West KM, Ahuja MMS, Bennett PH et al. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361-72.
35. Ronnemaa T, Laakso M, Kaillo V, Pyorala K, Marniemi J, Puukka P. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin dependent diabetic patients. Am J Epidemiol 1989; 130: 632-45.
36. Farese RV Jr, Yost TW, Eckel RH. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 1991; 40: 214-6.
37. Baynes C, Henderson AD, Anyaoku W et al. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabetic Med 1991; 8: 560-6.
38. Eliasson B, Attvall S, Taskinen M-R, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994; 14: 1946-50.
39. Arai T, Yamashita S, Hirano K et al. Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994; 14: 1129-36.
40. Blades B, Vega GL, Grundy GM. Activities of lipoprotein lipase and hepatic triglyceride lipase in post-heparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 1993; 13: 1227-35.